HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- NIH initiative to ‘rigorously evaluate’ benefits, harms of evolving cancer screening technologies Jennifer Byrne
-
- Commentary: It’s in your DNA Nicholas J. Petrelli, MD, FACS
- AI partners with liquid biopsy for ‘robust’ identification of women with ovarian cancer Josh Friedman
- At same PSA level, Black men more likely than white men to have prostate cancer Mark Leiser
- ‘Best expectation’: Vaccine responses may prevent, delay cancer relapse Josh Friedman
- Biomarkers may predict gastrointestinal symptoms during chemotherapy Jennifer Byrne; Alexandre Chan, PharmD, MPH; Daniela Arcos
- Childhood cancer survivors at greater risk for death after major cardiovascular event Jennifer Byrne; Wendy J. Bottinor, MD
- Devices implanted into brain tumors during surgery may guide treatment Jennifer Byrne; Pier Paolo Peruzzi, MD, PhD
- Durvalumab improves survival in limited-stage small cell lung cancer Mark Leiser
-
- Durvalumab regimen improves 3-year survival in advanced biliary tract cancers Mark Leiser
- Educational video helps ‘empower’ Black men to take control of prostate cancer risk Josh Friedman
- ‘Exciting’ results show anito-cel CAR-T is safe, durable for high-risk multiple myeloma Drew Amorosi
- FDA grants accelerated approval to Brukinsa for advanced follicular lymphoma Matthew Shinkle
- FDA panel backs residual disease as ‘reasonable surrogate’ endpoint in myeloma trials Josh Friedman
- Head and neck cancer survivors have elevated risk for stroke Matthew Shinkle
- Immunotherapy combination improves survival in advanced liver cancer Matthew Shinkle
- Krazati slows disease progression in certain patients with lung cancer Matthew Shinkle
-
- Language minimizing adverse events in abstracts ‘harmful,’ can affect patient care Josh Friedman
- New ASCO president aims to improve access, return ‘humanity’ to cancer care Jennifer Byrne; Robin T. Zon, MD, FACP, FASCO
- New blood test close to ‘cracking the code’ on pancreatic cancer early detection Matthew Shinkle
- Next-generation PARP inhibitor shows clinical benefit in certain patients with breast cancer Matthew Shinkle
- Prevalence of functional limitations more than doubles among cancer survivors Matthew Shinkle
- Quality improvement project bridges ‘significant gap’ in biomarker testing for lung cancer Jennifer Byrne; Molly Mendenhall, LSSBB, RN, BSN
- Radiation oncologist calls on field to ‘advocate and educate’ as numbers fall Josh Friedman
- Regimen improves OS in diffuse large B-cell lymphoma Matthew Shinkle
-
- Smoking, vaping linked to higher symptom burden among cancer survivors Matthew Shinkle
- American Association for Cancer Research announces new president-elect Matthew Shinkle
- Cedars-Sinai Cancer appoints director of melanoma research Mark Leiser
- Dana-Farber appoints new head for drug discovery and research Matthew Shinkle
- National Comprehensive Cancer Network appoints board of directors chair, vice chair Mark Leiser
- Perlmutter Cancer Center at NYU Langone Health names new neuro-oncology chief